Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

3rd CRISPR 2.0 Summit 2022

Evvnt Promotion / evvnt
-
29.11.2022 - 01.12.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 08:30 - 17:00
 
Temi della conferenza
Recognised with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and innovative delivery platforms.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1278515-2?pid=4832

Speakers: Aditya Raguram, PhD Student David Liu Lab, Harvard University, Alexandra Crawley, Co-Founder and Senior Scientist, LifeEDIT, Amy Simon, Chief Medical Officer, Beam Therapeutics, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1278515-3?pid=4832
Ms. Min Ratcliffe
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2499.00 - USD 4897.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceHilfswerk AustriaÄrztekammer für WienSwiss Tropical and Public Health InstituteCharité International AcademyÖsterreichisches Rotes KreuzAGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation